The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4963087 6026240 I 4963087-3 20060317 20060331 EXP 2006-00652 MILLENIUM PHARMACEUTICALS INC. N 20060327 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4963087 1007131802 PS VELCADE 1 INTRAVENOUS BOLUS IV BOLUS U U 21602
4963087 1007173358 SS DOXORUBICIN (DOXORUBICIN) 2 INTRAVENOUS 30.00 MG/M2, INTRAVENOUS U U

Indications of drugs used

Event ID DRUG SEQ INDI PT
4963087 1007131802 LEUKAEMIA
4963087 1007173358 LEUKAEMIA

Outcome of event

Event ID OUTC COD
4963087 DE

Reactions reported

Event ID PT
4963087 DISEASE PROGRESSION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4963087 HP
4963087 SDY

Therapies reported

no results found